Amylin analogs present a strong alternative or complement to GLP-1 receptor agonists, potentially eliciting higher-quality ...
Equities research analysts at Leerink Partners assumed coverage on shares of Elanco Animal Health (NYSE:ELAN – Get Free ...
Investment analysts at Leerink Partners began coverage on shares of Climb Bio (NASDAQ:CLYM – Get Free Report) in a report released on Monday, MarketBeat reports. The brokerage set an “outperform” ...
Industry Veterans Grant Curry and Jason Truman Join Leerink Partners. BOSTON, Nov. 14, 2024 /PRNewswire/ -- Leerink Partners, a leading investment bank specializing in healthcare, announced today ...
Fintel on MSN2d
Leerink Partners Initiates Coverage of Elanco Animal Health (ELAN) with Market Perform RecommendationFintel reports that on December 2, 2024, Leerink Partners initiated coverage of Elanco Animal Health (NYSE:ELAN) with a ...
Fintel reports that on December 2, 2024, Leerink Partners initiated coverage of Zoetis (NYSE:ZTS) with a Outperform ...
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...
BOSTON, Oct. 22, 2024 /PRNewswire/ -- Leerink Partners' affiliate, MEDACorp, announced today the launch of a new division, the Center for Pharmacoeconomics (CPE), which will be dedicated to ...
AbbVie shares rose after a Leerink Partners analyst upgraded the stock's rating to outperform. The improved rating comes after ABBV stock previously fell nearly 19% this month after two drug study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback